Salma M. ALDALLAL. Ofatumumab as an Emerging Treatment Option for Chronic Lymphocytic Leukaemia Patients. Research Highlights in Disease and Health Research Vol. 2, [S. l.], p. 10–24, 2023. DOI: 10.9734/bpi/rhdhr/v2/9253F. Disponível em: https://stm.bookpi.org/RHDHR-V2/article/view/9611. Acesso em: 13 jun. 2026.